Proteomic Analysis of the Mammalian Nuclear Pore Complex
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Protein Signature of Human Skin Broblasts Allows the Study of The
Protein signature of human skin broblasts allows the study of the molecular etiology of rare neurological diseases Andreas Hentschel Leibniz-Institut fur Analytische Wissenschaften - ISAS eV Artur Czech Leibniz-Institut fur Analytische Wissenschaften - ISAS eV Ute Münchberg Leibniz-Institut fur Analytische Wissenschaften - ISAS eV Erik Freier Leibniz-Institut fur Analytische Wissenschaften - ISAS eV Ulrike Schara-Schmidt Universitat Duisburg-Essen Medizinische Fakultat Albert Sickmann Leibniz-Institut fur Analytische Wissenschaften - ISAS eV Jens Reimann Universitatsklinikum Bonn Andreas Roos ( [email protected] ) Leibniz-Institut fur Analytische Wissenschaften - ISAS eV https://orcid.org/0000-0003-2050-2115 Research Keywords: Allgrove syndrome, Aladin, AAAS, triple-A syndrome, Myopodin/Synaptopodin-2, Ataxin-2 Posted Date: December 16th, 2020 DOI: https://doi.org/10.21203/rs.3.rs-48014/v2 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Version of Record: A version of this preprint was published on February 9th, 2021. See the published version at https://doi.org/10.1186/s13023-020-01669-1. Page 1/29 Abstract Background: The elucidation of pathomechanisms leading to the manifestation of rare (genetically caused) neurological diseases including neuromuscular diseases (NMD) represents an important step toward the understanding of the genesis of the respective disease and might help to dene starting points for (new) therapeutic intervention concepts. However, these “discovery studies” are often limited by the availability of human biomaterial. Moreover, given that results of next-generation-sequencing approaches frequently result in the identication of ambiguous variants, testing of their pathogenicity is crucial but also depending on patient-derived material. -